For complex proteins like immunoglobulins, plant production systems provide breakthroughs in the cost, the scale of production, and the scope of molecules that can be efficiently manufactured.

Octapharma today welcomes the news that, for the first time in almost 30 years, NHS patients are receiving medicines made from UK-donated plasma. The plasma-derived medicinal products (PDMPs) ...